CHC LABS INC.
|
THYROID TESTING (84436,84439,84443,84479) |
|
|
017.50-017.56 |
Tuberculosis of thyroid gland unspecified origin |
|
183.0 |
Malignant neoplasm of ovary |
|
193 |
Malignant neoplasm of thyroid gland |
|
194.8 |
Malignant neoplasm of other endocrine glands and related structures |
|
198.89 |
Secondary malignant neoplasm of other specified sites |
|
220 |
Benign neoplasm of ovary |
|
226 |
Benign neoplasm of thyroid glands |
|
227.3 |
Benign neoplasm of pituitary gland and craniopharyngeal duct |
|
234.8 |
Carcinoma in situ of other specified sites |
|
237.4 |
Neoplasm of uncertain behavior of other and unspecified endocrine glands |
|
239.7 |
Neoplasm of unspecified nature of endocrine glands and other parts of nervous system |
|
240.0-240.9 |
Goiter specified as simple |
|
241.0-241.9 |
Nontoxic uninodular goiter |
|
242.00-242.91 |
Toxic diffuse goiter without thyrotoxic crisis or storm |
|
243 |
Congenital hypothyroidism |
|
244.0-244.9 |
Postsurgical hypothyroidism |
|
245.0-245.9 |
Acute thyroiditis |
|
246.0-246.9 |
Disorders of thyrocalcitonin secretion |
|
250.00-250.93 |
Diabetes mellitus without complication type II or unspecified type not stated as uncontrolled |
|
252.1 |
Hypoparathyroidism |
|
253.1 |
Other and unspecified anterior pituitary hyperfunction |
|
253.2 |
Panhypopituitarism |
|
253.3 |
Pituitary dwarfism |
|
253.4 |
Other anterior pituitary disorders |
|
253.7 |
Iatrogenic pituitary disorders |
|
255.2 |
Adrenogenital disorders |
|
255.4 |
Corticoadrenal insufficiency |
|
256.31 |
Premature menopause |
|
256.39 |
Other ovarian failure |
|
257.2 |
Other testicular hypofunction |
|
258.0-258.9 |
Polyglandular activity in multiple endocrine adenomatosis |
|
262 |
Other severe protein-calorie malnutrition |
|
263.0-263.9 |
Malnutrition of moderate degree |
|
266.0 |
Ariboflavinosis |
|
272.0 |
Pure hypercholesterolemia |
|
272.2 |
Mixed hyperlipidemia |
|
272.4 |
Other and unspecified hyperlipidemia |
|
275.40-275.49 |
Unspecified disorder of calcium metabolism |
|
276.0 |
Hyperosmolality and/or hypernatremia |
|
276.1 |
Hyposmolality and/or hyponatremia |
|
278.3 |
Hypercarotinemia |
|
279.4 |
Autoimmune disease not elsewhere classified |
|
281.0 |
Pernicious anemia |
|
281.9 |
Unspecified deficiency anemia |
|
283.0 |
Autoimmune hemolytic anemias |
|
285.9 |
Anemia unspecified |
|
290.0 |
Senile dementia uncomplicated |
|
290.10-290.13 |
Presenile dementia uncomplicated |
|
290.20-290.21 |
Senile dementia with delusional features |
|
290.3 |
Senile dementia with delirium |
|
293.0-293.1 |
Acute delirium |
|
293.81-293.89 |
Organic delusional syndrome |
|
294.8 |
Other specified organic brain syndromes (chronic) |
|
296.00-296.99 |
Manic affective disorder, single episode unspecified degree |
|
297.0 |
Paranoid state simple |
|
297.1 |
Paranoia |
|
297.9 |
Unspecified paranoid state |
|
298.3 |
Acute paranoid reaction |
|
300.00-300.09 |
Anxiety state unspecified |
|
307.9 |
Other and unspecified special symptoms or syndromes not elsewhere classified |
|
310.1 359.5 368.2 Diplopia 372.71 372.73 Conjunctival 374.41 374.82 376.21 Thyrotoxic 376.22 Exophthalmic 376.30-376.31 Exophthalmos 376.33-376.34 378.50-378.55 401.0-401.9 403.00-403.91 404.00-404.93 423.9 425.7 427.0 427.2 427.31 Atrial 427.89 427.9 428.0 428.1 429.3 Cardiomegaly 511.9 518.81 Organic personality syndrome |
|
|
311 |
Depressive disorder, not elsewhere classified |
|
327.00 |
Organic insomnia, unspecified |
|
327.01 |
Insomnia due to medical condition classified elsewhere |
|
327.09 |
Other organic insomnia |
|
327.29 |
Other organic sleep |
|
327.52 |
Sleep related leg cramp |
|
327.8 |
Other organic sleep disorders |
|
331.0-331.2 |
Alzheimer’s disease |
|
333.1 |
Essential and other specified forms of tremor |
|
333.99 |
Other extrapyramidal diseases and abnormal movement disorders |
|
354.0 |
Carpal tunnel syndrome |
|
356.9 |
Unspecified idiopathic peripheral neuropathy |
|
358.1 |
Myasthenic syndromes in diseases classified elsewhere |
|
Myopathy in endocrine diseases classified elsewhere |
|
|
359.9 |
Myopathy unspecified |
|
Hyperemia of conjunctiva |
|
|
edema |
|
|
Lid reaction or lag |
|
|
Edema of eyelid |
|
|
exophthalmos |
|
|
ophthalmoplegia |
|
|
unspecified |
|
|
Orbital edema or congestion |
|
|
Paralytic strabismus unspecified |
|
|
Malignant essential hypertension |
|
|
Malignant hypertensive renal disease without renal failure |
|
|
Malignant hypertensive heart and renal disease without heart failure or renal failure |
|
|
Unspecified disease of pericardium |
|
|
Nutritional and metabolic cardiomyopathy |
|
|
Paroxysmal supraventricular tachycardia |
|
|
Paroxysmal tachycardia unspecified |
|
|
fibrillation |
|
|
Other specified cardiac dysrhythmias |
|
|
Cardiac dysrhythmia unspecified |
|
|
Congestive heart failure unspecified |
|
|
Left heart failure |
|
|
Unspecified pleural effusion |
|
|
Acute respiratory failure |
|
529.8 560.1 Paralytic 564.00-564.02 Unspecified 564.09 Other 564.7 568.82 625.3 Dysmenorrhea 626.0-626.2 626.4 648.10-648.14 676.20-676.24 698.9 701.1 Keratoderma 703.8 704.00-704.09 Alopecia, 709.01 Vitiligo 710.0-710.9 728.2 728.9 729.1 729.82 730.30-730.39 733.02 Idiopathic 733.09 Other 750.15 Macroglossia 759.2 780.01 Coma 780.02 780.09 780.50-780.52 780.6 Fever 780.71-780.79 780.8 Hyperhidrosis 780.99 781.0 781.3 782.0 782.3 Edema 782.8 782.9 783.1 783.21 783.6 Polyphagia 784.1 Throat 784.49 784.5 785.0 Tachycardia 785.9
|
786.09 |
|
786.1 |
|
787.2 |
|
787.91-787.99 |
|
789.5 |
|
Respiratory abnormality, other |
|
|
Stridor |
|
|
Dysphagia |
|
|
Diarrhea |
|
|
Other specified conditions of the tongue |
|
|
ileus |
|
|
constipation |
|
|
constipation |
|
|
Megacolon, other then Hirschsprung’s |
|
|
Peritoneal effusion (chronic) |
|
|
Absence of menstruation |
|
|
Irregular menstrual cycle |
|
|
Thyroid dysfunction of mother complicating pregnancy, childbirth, or the puerperium unspecified as to episode of care |
|
|
Engorgement of breasts associated with childbirth unspecified as to episode of care |
|
|
Unspecified pruritic disorder |
|
|
acquired |
|
|
Other specified diseases of nail |
|
|
unspecified |
|
|
Systemic lupus erythematosus |
|
|
Muscular wasting and disuse atrophy not elsewhere classified |
|
|
Unspecified disorder of muscle ligament and fascia |
|
|
Myalgia and myositis, unspecified |
|
|
Cramp of limb |
|
|
Periostitis without osteomyelitis involving unspecified site |
|
|
osteoporosis |
|
|
osteoporosis |
|
|
Anomalies of other endocrine glands congenital |
|
|
Transient alteration of awareness |
|
|
Alteration of consciousness, other |
|
|
Unspecified sleep disturbance |
|
|
Chronic fatigue syndrome |
|
|
Other general symptoms |
|
|
Abnormal involuntary movements |
|
|
Lack of coordination |
|
|
Disturbance of skin sensation |
|
|
Changes in skin texture |
|
|
Other symptoms involving skin and integumentary tissues |
|
|
Abnormal weight gain |
|
|
Loss of weight |
|
|
pain |
|
|
Other voice disturbance |
|
|
Other speech disturbance |
|
|
unspecified |
|
|
785.1 |
Palpitations |
|
Other symptoms involving cardiovascular system |
|
Ascites
|
793.9 |
Nonspecific abnormal findings on radiological and other examination of other sites of body |
|
794.5 |
Nonspecific abnormal results of function study of thyroid |
|
796.1 |
Abnormal reflex |
|
799.2 |
Nervousness |
|
990 |
Effects of radiation unspecified |
|
V10.87 Personal history of malignant neoplasm of thyroid |
|
|
V10.88 |
Personal history of malignant neoplasm of other endocrine glands and related structures |
|
V12.2 |
Personal history of endocrine metabolic and immunity disorders |
|
V58.69 |
Long-term (current) use of other medications |
|
V67.00-V67.9 |
Follow-up examination following unspecified surgery |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|